Top Markets
#1 Celer Network Celer Network +49.10%
#2 Gravity Gravity +24.44%
#3 Galxe Galxe +23.88%
#4 ICON ICON +13.39%
#5 MemeCore MemeCore +13.25%
#6 Cartesi Cartesi +12.87%
#7 Zilliqa Zilliqa +10.95%
#8 Genius Genius +10.65%
#9 Ontology Gas Ontology Gas +9.33%
#10 CyberDEX CyberDEX +7.13%
Coin of the day
Celer Network Celer Network
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Rang în acțiuni #40225
Fusion Antibodies plc operates as a contract research organization (CRO),... Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Preț acțiune
$0.1559364
Ultima sincronizare: 2026-09-18
Capitalizare de piață
$195.17K
Schimbare (1 zi)
6.60%
Schimbare (1 an)
-30.91%
Țară
GB
Tranzacționează Fusion Antibodies plc (FAB)

Categorie

Healthcare
Venituri pentru Fusion Antibodies plc (FAB)
Venituri în Sep 2025 TTM: $2.15M
Conform celor mai recente rapoarte financiare ale Fusion Antibodies plc, venitul actual al companiei (TTM) este $2.15M. În anul 2024, compania a avut un venit de $1.43M o scădere comparativ cu venitul din anul 2023, care a fost de $3.58M. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Fusion Antibodies plc din 2013 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
2026 (TTM) $2.15M -15.49%
2025 $2.54M 77.00%
2024 $1.43M -59.95%
2023 $3.58M -43.24%
2022 $6.31M 9.89%
2021 $5.74M 18.80%
2020 $4.83M 70.09%
2019 $2.84M -24.66%
2018 $3.77M 57.07%
2017 $2.40M 12.81%
2016 $2.13M 57.86%
2015 $1.35M 11.90%
2014 $1.20M 95.78%
2013 $615.46K 0.00%
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 588,305.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 280,545.95%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B 103,744.77%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B 733,726.73%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH